ATM and cancer: Patients with A-T, ATLD1, and NBS show a predisposition to cancers, including breast cancer, bladder cancer, melanoma, lung cancer, colon cancer, leukemia, and lymphoma, thereby implying the tumorigenic effects of mutations in ATM, MRE11A, and NBS1 genes.